An Australian stem cell and regenerative medicine company

January 28, 2022

Cynata breaks into the second largest pharmaceutical market in the world

CEO Dr Ross Macdonald joined ausbiz to discuss the development and the outlook for Cynata in 2022 following the receipt of a patent from Japan, the world’s second largest stem cell market. 

Read Article